Literature DB >> 30387375

MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer.

Quanfu Yang1.   

Abstract

MiRNA-5195-3p (miR-5195-3p), a recently discovered and poorly studied miRNA, has been reported to suppress bladder cancer cell behavior. However, its regulatory role in non-small cell lung cancer (NSCLC) remains unclear. Here, the expression of miR-5195-3p was found to be reduced in NSCLC tissues and cells. The in vitro experiments showed that miR-5195-3p upregulation repressed cell proliferation, migration and invasion by CCK-8 and transwell assays. In addition, MYO6 was predicted and confirmed as a potential target of miR-5195-3p by Bioinformatics analysis, Luciferase reporter assay and western blot analysis. There was significantly negative correlation between miR-5195-3p and MYO6 in NSCLC tissues. Furthermore, MYO6 knockdown exhibited similar effects to those of miR-5195-3p overexpression in NSCLC cells, and restored MYO6 expression reversed the inhibitory effects of miR-5195-3p. Therefore, these results demonstrate that miR-5195-3p functions as a tumor suppressor by directly modulating MYO6 expression in NSCLC cells, and may be an innovative candidate target for NSCLC therapy.

Entities:  

Keywords:  MYO6; Non-small cell lung cancer; cell proliferation; miR-5195-3p; mobility

Mesh:

Substances:

Year:  2018        PMID: 30387375     DOI: 10.1080/09168451.2018.1540288

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  12 in total

1.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Authors:  Erez Uzuner; Gizem Tugçe Ulu; Sevim Beyza Gürler; Yusuf Baran
Journal:  Methods Mol Biol       Date:  2022

2.  Aspirin ameliorates lung cancer by targeting the miR-98/WNT1 axis.

Authors:  Huizhu Gan; Lin Lin; Nanjun Hu; Yang Yang; Yu Gao; Yu Pei; Kang Chen; Butong Sun
Journal:  Thorac Cancer       Date:  2019-02-12       Impact factor: 3.500

3.  MicroRNA-5195-3p enhances the chemosensitivity of triple-negative breast cancer to paclitaxel by downregulating EIF4A2.

Authors:  Mei Liu; Can Gong; Renyuan Xu; Yu Chen; Xiaodong Wang
Journal:  Cell Mol Biol Lett       Date:  2019-07-01       Impact factor: 5.787

4.  Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma.

Authors:  Qingyun Duan; Mei Xu; Meng Wu; Xiong Zhang; Min Gan; Hongbing Jiang
Journal:  Cancer Med       Date:  2020-03-04       Impact factor: 4.452

5.  TRPV4 induces apoptosis via p38 MAPK in human lung cancer cells.

Authors:  Yanyan Zhao; Jiaying Wang; Xuehui Liu
Journal:  Braz J Med Biol Res       Date:  2021-10-18       Impact factor: 2.590

6.  MicroRNA-5195-3p alleviates high glucose‑induced injury in human ARPE-19 cells by targeting GMFB.

Authors:  Jingjing Liu; Yongsheng Hou; Lili Lin; Nannan Yu; Yanyan Zhang
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

7.  LINC01224 promotes colorectal cancer progression through targeting miR-485-5p/MYO6 axis.

Authors:  Jingfeng Gu; Liang Dong; Yun Wang; Wenjia Nie; Wencong Liu; Ji-An Zhao
Journal:  World J Surg Oncol       Date:  2021-09-17       Impact factor: 2.754

8.  MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9.

Authors:  Zhihua Liang; Jianhui Xu; Zhancheng Ma; Guihua Li; Wanhong Zhu
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

9.  Hsa_circ_0000231 knockdown inhibits the glycolysis and progression of colorectal cancer cells by regulating miR-502-5p/MYO6 axis.

Authors:  Yanhe Liu; Hui Li; Xiaoyi Ye; Anlong Ji; Xiangwei Fu; Haishan Wu; Xiangyong Zeng
Journal:  World J Surg Oncol       Date:  2020-09-29       Impact factor: 2.754

10.  Long Non-Coding RNA JPX Contributes to Tumorigenesis by Regulating miR-5195-3p/VEGFA in Non-Small Cell Lung Cancer.

Authors:  Guanglian Li; Xinrui Li; Chao Yuan; Caifeng Zhou; Xinxin Li; Jinfang Li; Bin Guo
Journal:  Cancer Manag Res       Date:  2021-02-12       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.